US0758871091 - Common Stock
BECTON DICKINSON AND CO
NYSE:BDX (4/24/2024, 7:04:00 PM)
After market: 233.83 0 (0%)233.83
-0.53 (-0.23%)
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 73,000 full-time employees. The firm is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The firm's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The firm's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The firm's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
BECTON DICKINSON AND CO
One Becton Drive
Franklin Lakes NEW JERSEY 07417
P: 12018476800
CEO: Thomas E. Polen
Employees: 73000
Website: https://www.bd.com/
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business...
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of...
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial...
Want quality picks and reliable income at a discount? Check out these Dividend Aristocrats trading at 52-week lows.
Although 3M shareholders have reason to dump the Solventum spinoff, SOLV stock could be intriguing at the right price.
Here you can normally see the latest stock twits on BDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: